Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

New Delhi: In a major crackdown on the sale of expired and substandard products, the Central Range team of Delhi Police Crime Branch has arrested one person and seized nearly 900 kg of expired grocery items — including baby food supplements, cosmetics, and personal care products — from a shop near Kapashera Border in Delhi.

Acting on specific and credible information received on April 8, 2026, a team led by Inspector Yashendra Singh under ACP Satendra Mohan conducted a raid on the premises. The shopkeeper, identified as Abdul Mannan Khan alias Monu (34 years, resident of Bijwasan, Delhi), was apprehended on the spot. A customer present during the raid also complained that she had purchased food items the previous day, all of which turned out to be expired, causing her financial loss.

The seized items included:

Maida (Rajdhani/Fortune)

Sooji (Rajdhani/Fortune)

Supreme Harvest Poha and Rawa

Spices (Goldie/Everest)

Peanut butter

Baby food supplements (Nestle/Dexo Grow)

Various cosmetic and personal care products

Pulses

In addition, approximately 2,000 kg of dairy products (curd and cheese) were destroyed on the spot in the presence of officials from the Food Safety and Drug Control Department. Officials from the same department inspected the premises and collected samples for further testing.

During interrogation, the accused revealed that he had been running this illegal operation for several years. Previously a street vegetable vendor, he came into contact with warehouse personnel in 2022 and began procuring expired, near-expiry, or damaged food and cosmetic products at throwaway prices. He would then store them in his shop and sell them to unsuspecting customers at discounted rates, presenting them as genuine products to attract higher footfall and generate quick profits. This practice not only cheated consumers financially but also posed serious health risks, as consumption or use of expired items can lead to harmful effects.

A case has been registered vide FIR No. 79/2026 dated 09.04.2026 at PS Crime Branch under Sections 275, 318(4), 125, 61(2) of the Bharatiya Nyaya Sanhita (BNS) along with Sections 51/59 of the Food Safety and Standards Act, 2006. All seized items and related evidence have been taken into possession as per legal procedure. Further investigation is in progress.

The operation highlights the continued vigilance of Delhi Police Crime Branch against food adulteration and the sale of expired products that endanger public health, especially vulnerable groups such as infants and children who consume baby food supplements.

Related Posts

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

Washington:  On March 18, 2026, the U.S. Food and Drug Administration (FDA) issued a draft guidance titled General Considerations for the Use of New Approach Methodologies in Drug Development. The…

IPC releases draft NFI-2026 to promote rational use of medicines

Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

US market to dent India pharma earnings even as domestic growth remains firm

US market to dent India pharma earnings even as domestic growth remains firm

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg